A decade ago, these drugs tore apart the FDA. Today, they might be some patients' best hope

STAT·Apr 8

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Certain drugs that previously caused controversy at the FDA may now offer hope for some patients. The status of these drugs is being reevaluated, potentially bringing new treatment options for rare disease patients. However, the specifics of the drugs and their potential uses are unclear, with various reports discussing different medications and health issues.

Full coverage

The quest to save Grace — and clear the way for rare disease patients everywhere

STAT·5d ago

Recon: Amazon to sell Lilly’s weight-loss drug at kiosks in US; CDC delays report on COVID vaccine benefits

RAPS·Apr 9

INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain

MedShadow Foundation·Nov 3

Five years after disaster, a rare disease community gets new chance at treatment

STAT·May 11

Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests

STAT·Apr 8

View original report at STAT ↗

Fetching the latest headlines…